No association between genetically predicted C-reactive protein levels and colorectal cancer survival in Korean: two-sample Mendelian randomization analysis

키워드

참고문헌 (50)

1. Wu J, "Circulating C-reactive protein and colorectal cancer risk : a report from the Shanghai Men’s Health Study", Carcinogenesis, 34, pp.2799~2803 (2013)
2. Zhou B, "C-reactive protein, interleukin-6 and the risk of colorectal cancer : a meta-analysis", Cancer Causes Control, 25, pp.1397~1405 (2014)
3. Goyal A, "C-reactive protein and colorectal cancer mortality in U. S. adults", Cancer Epidemiol Biomarkers Prev, 23, pp.1609~1618 (2014)
4. Swede H, "Baseline serum C-reactive protein and death from colorectal cancer in the NHANES III cohort", Int J Cancer, 134, pp.1862~1870 (2014)
5. Partl R, "The elevated pre-treatment C-reactive protein predicts poor prognosis in patients with locally advanced rectal cancer treated with neo-adjuvant radiochemotherapy", Diagnostics(Basel), 10, pp.780~ (2020)
6. Yamamoto M, "Prognostic value of the combination of pre-and postoperative C-reactive protein in colorectal cancer patients", Surg Today, 48, pp.986~993 (2018)
7. Ishizuka M, "C-reactive protein is associated with distant metastasis of T3 colorectal cancer", Anticancer Res, 32, pp.1409~1415 (2012)
8. Fujikawa H, "Cumulative C-reactive protein in the perioperative period as a novel marker for oncological outcome in patients with colorectal cancer undergoing curative resection", J Anus Rectum Colon, 5, pp.281~290 (2021)
9. Stephensen BD, "C-reactive protein trajectory to predict colorectal anastomotic leak : PREDICT Study", Br J Surg, 107, pp.1832~1837 (2020)
10. Shrotriya S, "C-reactive protein is an important biomarker for prognosis tumor recurrence and treatment response in adult solid tumors : a systematic review", PLoS One, 10, pp.e0143080~ (2015)
11. Matsubara D, "The impact of postoperative inflammation on recurrence in patients with colorectal cancer", Int J Clin Oncol, 25, pp.602~613 (2020)
12. Woo HD, "Association between preoperative C-reactive protein level and colorectal cancer survival : a meta-analysis", Cancer Causes Control, 26, pp.1661~1670 (2015)
13. Liao CK, "Prognostic value of the C-reactive protein to albumin ratio in colorectal cancer : an updated systematic review and meta-analysis", World J Surg Oncol, 19, pp.139~ (2021)
14. He L, "Prognostic value of the Glasgow Prognostic Score or modified Glasgow Prognostic Score for patients with colorectal cancer receiving various treatments : a systematic review and meta-analysis", Cell Physiol Biochem, 51, pp.1237~1249 (2018)
15. Allin KH, "Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer", Crit Rev Clin Lab Sci, 48, pp.155~170 (2011)
16. Hartwig FP, "Two-sample Mendelian randomization : avoiding the downsides of a powerful, widely applicable but potentially fallible technique", Int J Epidemiol, 45, pp.1717~1726 (2016)
17. Ligthart S, "Genome analyses of >200, 000 individuals identify 58 loci for chronic inflammation and highlight pathways that link inflammation and complex disorders", Am J Hum Genet, 103, pp.691~706 (2018)
18. Kocarnik JM, "Multiancestral analysis of inflammation-related genetic variants and C-reactive protein in the population architecture using genomics and epidemiology study", Circ Cardiovasc Genet, 7, pp.178~188 (2014)
19. Vinayagamoorthy N, "New variants including ARG1 polymorphisms associated with C-reactive protein levels identified by genome-wide association and pathway analysis", PLoS One, 9, pp.e95866~ (2014)
20. Huang Y, "Genetic variants associated with circulating C-reactive protein levels and colorectal cancer survival : sex-specific and lifestyle factors specific associations", Int J Cancer, 150, pp.1447~1454 (2022)
21. Slattery ML, "Genetic variation in C-reactive protein in relation to colon and rectal cancer risk and survival", Int J Cancer, 128, pp.2726~2734 (2011)
22. Yang SH, "Association of C-reactive protein gene polymorphisms and colorectal cancer", Ann Surg Oncol, 18, pp.1907~1915 (2011)
23. Huang CJ, "Prognostic significance of C-reactive protein polymorphism and KRAS", BRAF in synchronous liver metastasis from colorectal cancer, 2013, pp.8, e65117~
24. Hua X, "Genetically predicted circulating C-reactive protein concentration and colorectal cancer survival : a Mendelian randomization consortium study", Cancer Epidemiol Biomarkers Prev, 30, pp.1349~1358 (2021)
25. Morimoto Y, "Ethnic differences in serum adipokine and C-reactive protein levels: the multiethnic cohort", Int J Obes(Lond), 38, pp.1416~1422 (2014)
26. Okada Y, "Genome-wide association study for C-reactive protein levels identified pleiotropic associations in the IL6 locus", Hum Mol Genet, 20, pp.1224~1231 (2011)
27. Kanai M, "Genetic analysis of quantitative traits in the Japanese population links cell types to complex human diseases", Nat Genet, 50, pp.390~400 (2018)
28. Kim Y, "Cohort profile : the Korean Genome and Epidemiology Study(KoGES)consortium", Int J Epidemiol, 46, pp.e20~ (2017)
29. Moon S, "The Korea Biobank Array : design and identification of coding variants associated with blood biochemical traits", Sci Rep, 9, pp.1382~ (2019)
30. Choi CK, "Association between ALDH2 polymorphism and esophageal cancer risk in South Koreans : a case-control study", BMC Cancer, 21, pp.254~ (2021)
31. Han MR, "Genome-wide association study in East Asians identifies two novel breast cancer susceptibility loci", Hum Mol Genet, 25, pp.3361~3371 (2016)
32. 최창균, "Association between ALDH2 Polymorphism and Gastric Cancer Risk in a Korean Population", Journal of Korean Medical Science, 35(17), pp.1~6 (2020), 대한의학회[DOI]
33. Lu Y, "Large-scale genome-wide association study of East Asians identifies loci associated with risk for colorectal cancer", Gastroenterology, 156, pp.1455~1466 (2019)
34. 최창균, "Association between ALDH2 and ADH1B Polymorphisms and the Risk for Colorectal Cancer in Koreans", Cancer Research and Treatment, 53(3), pp.754~762 (2021), 대한암학회[DOI]
35. Cho Y, "Mendelian randomization analysis with survival outcomes", Genet Epidemiol, 45, pp.16~23 (2021)
36. Yavorska OO, "MendelianRandomization : an R package for performing Mendelian randomization analyses using summarized data", Int J Epidemiol, 46, pp.1734~1739 (2017)
37. Brion MJ, "Calculating statistical power in Mendelian randomization studies", Int J Epidemiol, 42, pp.1497~1501 (2013)
38. Staley JR, "PhenoScanner : a database of human genotype-phenotype associations", Bioinformatics, 32, pp.3207~3209 (2016)
39. Ligthart S, "Bivariate genome-wide association study identifies novel pleiotropic loci for lipids and inflammation", BMC Genomics, 17, pp.443~ (2016)
40. Surakka I, "The impact of low-frequency and rare variants on lipid levels", Nat Genet, 47, pp.589~597 (2015)
41. Bowden J, "Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator", Genet Epidemiol, 40, pp.304~314 (2016)
42. Bowden J, "Mendelian randomization with invalid instruments : effect estimation and bias detection through Egger regression", Int J Epidemiol, 44, pp.512~525 (2015)
43. Prins BP, "Genome-wide analysis of health-related biomarkers in the UK Household Longitudinal Study reveals novel associations", Sci Rep, 7, pp.11008~ (2017)
44. Naitza S, "A genome-wide association scan on the levels of markers of inflammation in Sardinians reveals associations that underpin its complex regulation", PLoS Genet, 8, pp.e1002480~ (2012)
45. Han KH, "C-reactive protein promotes monocyte chemoattractant protein-1--mediated chemotaxis through upregulating CC chemokine receptor 2 expression in human monocytes", Circulation, 109, pp.2566~2571 (2004)
46. Theodoratou E, "Genome-wide scan of the effect of common nsSNPs on colorectal cancer survival outcome", Br J Cancer, 119, pp.988~993 (2018)
47. Phipps AI, "Common genetic variation and survival after colorectal cancer diagnosis : a genome-wide analysis", Carcinogenesis, 37, pp.87~95 (2016)
48. Ghuman S, "Serum inflammatory markers and colorectal cancer risk and survival", Br J Cancer, 116, pp.1358~1365 (2017)
49. Allin KH, "Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer", J Clin Oncol, 27, pp.2217~2224 (2009)
50. Zhao H, "Inflammation and tumor progression : signaling pathways and targeted intervention", Signal Transduct Target Ther, 6, pp.263~ (2021)

관련 논문AI추천